in order to assess the actual degree of activation of coagulation and fibrinolytic systems in liver disease , plasma levels of thrombin-antithrombin iii complex ( tat ) and plasmin-alpha 2-antiplasmin complex ( pap ) were measured together with cross-linked fibrin derivatives ( xdp ) , tissue-type plasminogen activator ( t-pa ) , and plasminogen activator inhibitor ( pai-1 ) in 31 patients with liver disease ( five patients with acute hepatitis , seven with chronic hepatitis , nine with liver cirrhosis , and ten with hepatocellular carcinoma ) .
C0032105
plasma
C0015982
fibrin